Corporate Banner
Satellite Banner
Technology Networks Header
Thursday, October 23, 2014
Technology Networks
 
Register | Sign in
Home Page>Products
  Product News
EMD Millipore Launches New Kits for Use on Gyros’ Immunoassay Platform
Wednesday, March 26, 2014
Ready-to-use kits are fully qualified for reliable use in clinical research.

Dolomite Continues to Release the Coolest Microfluidic Products
Friday, March 21, 2014
Dolomite planned to release Dropix in April 2014.

Biametrics Launches b-screen® Microarray Screening Device
Wednesday, March 19, 2014
Company develops b-portable® for early cancer and infection detection.

Dolomite Introduces Microfluidic System
Friday, February 28, 2014
Dolomite’s Telos system for high throughput droplet microfluidics.

Do you Want to Make the Move from Diagnostics to BiognostiX?
Thursday, February 20, 2014
Symposium ‘Leading the way from diagnostics to BiognostiX’ to be held on 27 February 2014 in UK.

Protea Announces Release of New Gel Protein Recovery System
Thursday, February 13, 2014
The Gel Protein Recovery GPR-850 System enables intact protein recovery from polyacrylamide gels for top-down proteomics applications.

Wako Life Sciences Receives AACC Award
Tuesday, February 04, 2014
Dr. Shinji Satomura and Dr. Henry Wada receives the award for the uTASWako i30 Immunoanalyzer.

At BiOS SCHOTT to Present a Variety of Glass Substrates for Use in Biotechnology
Friday, January 31, 2014
Specialty glass and in-house micro-structuring technology for top quality substrates.

Ostendum LOAC Nanodevices are Produced with SCIENION’s sciFLEXARRAYER SX
Thursday, January 30, 2014
Best solution to precisely and accurately spot antibodies onto nanodevices.

<< 1 2 3 4 5 6 7 >>
Showing Results 11 - 20 of 1047
Scientific News
Dutch Public-Private Partnership Invests 28 Million Euro on Research into Personalized Medicine
The Netherlands' three Top Institutes for life-science research announce a joint research target to bring personalized medicine closer to reality.
FDA Grants Orphan Drug Status for Quark's QPI-1002 for the Prophylaxis of DGF in Kidney Transplant Patients
Company completes enrollment and dosing in the dose-escalation safety portion of a Phase 1/2 study.
Oncolytics Biotech® Receives MHRA Approval to Conduct Phase 3 Trial for REOLYSIN®
Conducting the trials in U.S. and Europe will allow Company to access the physicians that have worked with REOLYSIN in head and neck cancers.
Shenogen and Chemizon Announce Drug Discovery Collaboration Focused on Oncology and Endocrine Disorders
The agreement will create small molecule therapeutics targeting modulators of the ER-alpha 36 receptor.
Dutch Public-Private Partnership Invests 28 Million Euro on Research into Personalized Medicine
The Netherlands' three Top Institutes for life-science research announce a joint research target to bring personalized medicine closer to reality.
FDA Grants Orphan Drug Status for Quark's QPI-1002 for the Prophylaxis of DGF in Kidney Transplant Patients
Company completes enrollment and dosing in the dose-escalation safety portion of a Phase 1/2 study.
Oncolytics Biotech® Receives MHRA Approval to Conduct Phase 3 Trial for REOLYSIN®
Conducting the trials in U.S. and Europe will allow Company to access the physicians that have worked with REOLYSIN in head and neck cancers.
Skyscraper Banner
Skyscraper Banner
Follow TechNetcom1 on Twitter
Technology Networks Ltd. on LinkedIn
Go to LabTube.tv
Go to Lab-on-a-Chip RSS Feed